Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and neostigmine bromide

arg-3-hyp-7-phe-bradykinin has been researched along with neostigmine bromide in 1 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)
Trials
(arg-3-hyp-7-phe-bradykinin)
Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)
Studies
(neostigmine bromide)
Trials
(neostigmine bromide)
Recent Studies (post-2010) (neostigmine bromide)
522343016

Protein Interaction Comparison

ProteinTaxonomyarg-3-hyp-7-phe-bradykinin (IC50)neostigmine bromide (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.0594
AcetylcholinesteraseHomo sapiens (human)0.1112
AcetylcholinesteraseRattus norvegicus (Norway rat)0.9813
CholinesteraseEquus caballus (horse)0.07
Muscarinic acetylcholine receptorCavia porcellus (domestic guinea pig)0.045

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1

Other Studies

1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and neostigmine bromide

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008